Lam KO - Search Results

1

A Comprehensive Human Gastric Cancer Organoid Biobank Captures Tumor Subtype Heterogeneity and Enables Therapeutic Screening.

Yan HHN, Siu HC, Law S, Ho SL, Yue SSK, Tsui WY, Chan D, Chan AS, Ma S, Lam KO, Bartfeld S, Man AHY, Lee BCH, Chan ASY, Wong JWH, Cheng PSW, Chan AKW, Zhang J, Shi J, Fan X, Kwong DLW, Mak TW, Yuen ST, Clevers H, Leung SY. Yan HHN, et al. Among authors: lam ko. Cell Stem Cell. 2018 Dec 6;23(6):882-897.e11. doi: 10.1016/j.stem.2018.09.016. Epub 2018 Oct 18. Cell Stem Cell. 2018. PMID: 30344100 Free article.

2

Association of exon 19 and 21 EGFR mutation patterns with treatment outcome after first-line tyrosine kinase inhibitor in metastatic non-small-cell lung cancer.

Lee VH, Tin VP, Choy TS, Lam KO, Choi CW, Chung LP, Tsang JW, Ho PP, Leung DK, Ma ES, Liu J, Shek TW, Kwong DL, Leung TW, Wong MP. Lee VH, et al. Among authors: lam ko. J Thorac Oncol. 2013 Sep;8(9):1148-55. doi: 10.1097/JTO.0b013e31829f684a. J Thorac Oncol. 2013. PMID: 23945384 Free article.

3

Treatment outcomes of postradiation second head and neck malignancies managed by a multidisciplinary approach.

Chung J, Lee V, Tsang R, Chan J, Kwong DL, Lam KO, Sze HC, Leung TW. Chung J, et al. Among authors: lam ko. Head Neck. 2015 Jun;37(6):815-22. doi: 10.1002/hed.23674. Epub 2014 Jun 19. Head Neck. 2015. PMID: 24623597

4

Prognostic Significance of Standardized Uptake Value of Lymph Nodes on Survival for Stage III Non-small Cell Lung Cancer Treated With Definitive Concurrent Chemoradiotherapy.

Lee VH, Chan WW, Lee EY, Choy TS, Ho PP, Leung DK, Lam KO, Kwong DL, Leung TW, Khong PL. Lee VH, et al. Among authors: lam ko. Am J Clin Oncol. 2016 Aug;39(4):355-62. doi: 10.1097/COC.0000000000000070. Am J Clin Oncol. 2016. PMID: 24710123

5

Efficacy and safety of afatinib in Chinese patients with EGFR-mutated metastatic non-small-cell lung cancer (NSCLC) previously responsive to first-generation tyrosine-kinase inhibitors (TKI) and chemotherapy: comparison with historical cohort using erlotinib.

Lee VH, Leung DK, Choy TS, Lam KO, Lam PM, Leung TW, Kwong DL. Lee VH, et al. Among authors: lam pm, lam ko. BMC Cancer. 2016 Feb 24;16:147. doi: 10.1186/s12885-016-2201-9. BMC Cancer. 2016. PMID: 26911310 Free PMC article. Clinical Trial.

6

Dosimetric Predictors of Hypothyroidism After Radical Intensity-modulated Radiation Therapy for Non-metastatic Nasopharyngeal Carcinoma.

Lee V, Chan SY, Choi CW, Kwong D, Lam KO, Tong CC, Sze CK, Ng S, Leung TW, Lee A. Lee V, et al. Among authors: lam ko. Clin Oncol (R Coll Radiol). 2016 Aug;28(8):e52-60. doi: 10.1016/j.clon.2016.05.004. Epub 2016 May 24. Clin Oncol (R Coll Radiol). 2016. PMID: 27235379

7

Correlation of PD-L1 Expression of Tumor Cells with Survival Outcomes after Radical Intensity-Modulated Radiation Therapy for Non-Metastatic Nasopharyngeal Carcinoma.

Lee VH, Lo AW, Leung CY, Shek WH, Kwong DL, Lam KO, Tong CC, Sze CK, Leung TW. Lee VH, et al. Among authors: lam ko. PLoS One. 2016 Jun 24;11(6):e0157969. doi: 10.1371/journal.pone.0157969. eCollection 2016. PLoS One. 2016. PMID: 27341634 Free PMC article.

8

Radiation recall after capecitabine in a patient with recurrent nasopharyngeal carcinoma: a case report.

Lee V, Lam KO, Kwong D, Leung TW. Lee V, et al. Among authors: lam ko. J Med Case Rep. 2016 Sep 7;10(1):247. doi: 10.1186/s13256-016-1033-1. J Med Case Rep. 2016. PMID: 27604462 Free PMC article.

9

Hyperfractionation compared to standard fractionation in intensity-modulated radiation therapy for patients with locally advanced recurrent nasopharyngeal carcinoma.

Lee VH, Kwong DL, Leung TW, Ng SC, Lam KO, Tong CC, Sze CK. Lee VH, et al. Among authors: lam ko. Eur Arch Otorhinolaryngol. 2017 Feb;274(2):1067-1078. doi: 10.1007/s00405-016-4339-0. Epub 2016 Oct 13. Eur Arch Otorhinolaryngol. 2017. PMID: 27738820 Clinical Trial.

10

Metronomic oral cyclosphosphamide as third-line systemic treatment or beyond in patients with inoperable locoregionally advanced recurrent or metastatic nasopharyngeal carcinoma.

Lee VHF, Kwong DLW, Lam KO, Lai YC, Li Y, Tong CC, Ho PPY, Chan WL, Wong LS, Leung DKC, Chan SY, Chan FT, Leung TW, Lee AWM. Lee VHF, et al. Among authors: lam ko. Medicine (Baltimore). 2017 Apr;96(15):e6518. doi: 10.1097/MD.0000000000006518. Medicine (Baltimore). 2017. PMID: 28403082 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

127 results

Search Page